| 0 |
BLOOD CHROMOGRANIN A |
4 |
0.4444 |
| 1 |
GENITOURINARY TRACT NEOPLASM |
11 |
0.1325 |
| 2 |
REST REGIMEN |
6 |
0.1250 |
| 3 |
INSULIN-LIKE GROWTH FACTOR ABNORMAL |
12 |
0.1062 |
| 4 |
PITUITARY TUMOUR REMOVAL |
9 |
0.0947 |
| 5 |
CARCINOID HEART DISEASE |
8 |
0.0879 |
| 6 |
CARCINOID CRISIS |
18 |
0.0796 |
| 7 |
HEPATIC EMBOLISATION |
6 |
0.0759 |
| 8 |
GROWTH HORMONE DEFICIENCY |
30 |
0.0756 |
| 9 |
STOMATITIS HAEMORRHAGIC |
9 |
0.0738 |
| 10 |
BLOOD GROWTH HORMONE INCREASED |
41 |
0.0735 |
| 11 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
101 |
0.0708 |
| 12 |
SERUM SEROTONIN INCREASED |
23 |
0.0648 |
| 13 |
CYTOREDUCTIVE SURGERY |
4 |
0.0645 |
| 14 |
BLOOD CHROMOGRANIN A INCREASED |
27 |
0.0588 |
| 15 |
METASTASES TO SPINAL CORD |
11 |
0.0567 |
| 16 |
BILIRUBIN URINE PRESENT |
6 |
0.0504 |
| 17 |
CARCINOID TUMOUR PULMONARY |
12 |
0.0498 |
| 18 |
PELVIC NEOPLASM |
16 |
0.0462 |
| 19 |
CARCINOID SYNDROME |
15 |
0.0414 |
| 20 |
BLOOD GROWTH HORMONE ABNORMAL |
5 |
0.0410 |
| 21 |
PRODUCT ADMINISTERED BY WRONG PERSON |
13 |
0.0340 |
| 22 |
INJECTION SITE GRANULOMA |
8 |
0.0338 |
| 23 |
BENIGN PANCREATIC NEOPLASM |
6 |
0.0316 |
| 24 |
GALLBLADDER NEOPLASM |
4 |
0.0315 |
| 25 |
BLOOD GROWTH HORMONE DECREASED |
6 |
0.0297 |
| 26 |
NEUROENDOCRINE CARCINOMA METASTATIC |
7 |
0.0285 |
| 27 |
PRODUCT INEFFECTIVE |
22 |
0.0280 |
| 28 |
LACK OF APPLICATION SITE ROTATION |
4 |
0.0265 |
| 29 |
METASTASES TO ABDOMINAL CAVITY |
12 |
0.0244 |
| 30 |
FAT TISSUE DECREASED |
9 |
0.0231 |
| 31 |
LACK OF ADMINISTRATION SITE ROTATION |
7 |
0.0230 |
| 32 |
PITUITARY TUMOUR BENIGN |
36 |
0.0221 |
| 33 |
HEPATIC NEOPLASM |
68 |
0.0208 |
| 34 |
SALPINGECTOMY |
11 |
0.0192 |
| 35 |
PANCREATIC NEUROENDOCRINE TUMOUR |
12 |
0.0187 |
| 36 |
METASTASES TO HEART |
5 |
0.0166 |
| 37 |
THERAPEUTIC EMBOLISATION |
5 |
0.0160 |
| 38 |
HEPATECTOMY |
5 |
0.0160 |
| 39 |
METASTASES TO THORAX |
4 |
0.0158 |
| 40 |
ACROMEGALY |
5 |
0.0158 |
| 41 |
FAECES PALE |
35 |
0.0157 |
| 42 |
TUMOUR PAIN |
20 |
0.0152 |
| 43 |
TOOTH DEPOSIT |
5 |
0.0144 |
| 44 |
PALLIATIVE CARE |
22 |
0.0144 |
| 45 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
5 |
0.0142 |
| 46 |
INJECTION SITE CYST |
4 |
0.0137 |
| 47 |
OOPHORECTOMY |
12 |
0.0134 |
| 48 |
NEUROENDOCRINE TUMOUR |
19 |
0.0134 |
| 49 |
RENAL ARTERY THROMBOSIS |
4 |
0.0129 |
| 50 |
WHITE COAT HYPERTENSION |
7 |
0.0129 |
| 51 |
TREATMENT DELAYED |
21 |
0.0121 |
| 52 |
METASTASES TO BONE MARROW |
6 |
0.0120 |
| 53 |
HYPOAESTHESIA EYE |
7 |
0.0119 |
| 54 |
ABDOMINAL CAVITY DRAINAGE |
5 |
0.0118 |
| 55 |
BRAIN NEOPLASM BENIGN |
6 |
0.0117 |
| 56 |
PSEUDOSTROKE |
4 |
0.0116 |
| 57 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
6 |
0.0113 |
| 58 |
BILIARY OBSTRUCTION |
14 |
0.0108 |
| 59 |
METASTASES TO STOMACH |
4 |
0.0102 |
| 60 |
INJECTION SITE MASS |
377 |
0.0102 |
| 61 |
PITUITARY TUMOUR |
15 |
0.0101 |
| 62 |
TUMOUR EXCISION |
8 |
0.0099 |
| 63 |
LACK OF INJECTION SITE ROTATION |
17 |
0.0097 |
| 64 |
PANCREATIC FAILURE |
17 |
0.0096 |
| 65 |
FAECAL VOMITING |
5 |
0.0094 |
| 66 |
NEUROGENIC SHOCK |
5 |
0.0092 |
| 67 |
MAGNESIUM DEFICIENCY |
4 |
0.0085 |
| 68 |
STEATORRHOEA |
22 |
0.0082 |
| 69 |
SITTING DISABILITY |
5 |
0.0081 |
| 70 |
GASTROINTESTINAL NEOPLASM |
7 |
0.0081 |
| 71 |
CARCINOID TUMOUR |
6 |
0.0081 |
| 72 |
PRODUCT SUPPLY ISSUE |
57 |
0.0080 |
| 73 |
INJECTION SITE NODULE |
87 |
0.0079 |
| 74 |
ABDOMINAL NEOPLASM |
7 |
0.0078 |
| 75 |
THYROID HORMONES DECREASED |
6 |
0.0075 |
| 76 |
SOLAR LENTIGO |
7 |
0.0074 |
| 77 |
SPINAL CORD NEOPLASM |
6 |
0.0069 |
| 78 |
MALIGNANT PERITONEAL NEOPLASM |
4 |
0.0068 |
| 79 |
INJECTION SITE SCAR |
19 |
0.0067 |
| 80 |
VENA CAVA THROMBOSIS |
11 |
0.0066 |
| 81 |
PALATAL DISORDER |
4 |
0.0066 |
| 82 |
OBSTRUCTIVE PANCREATITIS |
5 |
0.0065 |
| 83 |
BONE NEOPLASM |
7 |
0.0065 |
| 84 |
HEPATIC LESION |
28 |
0.0065 |
| 85 |
HEPATIC PAIN |
27 |
0.0063 |
| 86 |
BLOOD PRESSURE MEASUREMENT |
4 |
0.0062 |
| 87 |
FAECES SOFT |
45 |
0.0062 |
| 88 |
PROCEDURAL VOMITING |
4 |
0.0062 |
| 89 |
CORTISOL DECREASED |
7 |
0.0061 |
| 90 |
HAEMANGIOMA OF LIVER |
6 |
0.0060 |
| 91 |
PULMONARY PAIN |
17 |
0.0058 |
| 92 |
ADENOMA BENIGN |
5 |
0.0058 |
| 93 |
INCORRECT DRUG ADMINISTRATION RATE |
24 |
0.0056 |
| 94 |
PYELONEPHRITIS ACUTE |
11 |
0.0056 |
| 95 |
MENOPAUSAL SYMPTOMS |
13 |
0.0056 |
| 96 |
METASTASES TO LIVER |
98 |
0.0056 |
| 97 |
UTERINE PROLAPSE |
6 |
0.0055 |
| 98 |
CHOLANGITIS ACUTE |
4 |
0.0053 |
| 99 |
INJECTION SITE ABSCESS |
13 |
0.0052 |
| 100 |
HYPOPARATHYROIDISM |
4 |
0.0052 |
| 101 |
INJECTION SITE SCAB |
5 |
0.0052 |
| 102 |
BILIARY COLIC |
15 |
0.0052 |
| 103 |
METASTASES TO SPINE |
17 |
0.0051 |
| 104 |
REFLUX GASTRITIS |
6 |
0.0050 |
| 105 |
PROCEDURAL NAUSEA |
4 |
0.0050 |
| 106 |
INJECTION SITE DISCOMFORT |
52 |
0.0049 |
| 107 |
FLATULENCE |
279 |
0.0049 |
| 108 |
SCIATIC NERVE INJURY |
4 |
0.0048 |
| 109 |
TERMINAL STATE |
32 |
0.0048 |
| 110 |
GLUCOSE TOLERANCE IMPAIRED |
28 |
0.0047 |
| 111 |
EYE CONTUSION |
10 |
0.0047 |
| 112 |
INFECTED BITE |
4 |
0.0047 |
| 113 |
BILE DUCT STONE |
15 |
0.0047 |
| 114 |
HORMONE LEVEL ABNORMAL |
23 |
0.0047 |
| 115 |
HEPATIC MASS |
9 |
0.0047 |
| 116 |
ABNORMAL FAECES |
38 |
0.0046 |
| 117 |
NEOPLASM |
52 |
0.0045 |
| 118 |
ABDOMINAL MASS |
12 |
0.0045 |
| 119 |
CHOLECYSTITIS INFECTIVE |
12 |
0.0043 |
| 120 |
CHOLELITHIASIS |
137 |
0.0042 |
| 121 |
BILE DUCT STENOSIS |
5 |
0.0042 |
| 122 |
NEOPLASM PROGRESSION |
144 |
0.0041 |
| 123 |
DEVICE SAFETY FEATURE ISSUE |
4 |
0.0041 |
| 124 |
MASTECTOMY |
7 |
0.0040 |
| 125 |
CORONAVIRUS TEST POSITIVE |
4 |
0.0039 |
| 126 |
DISCOURAGEMENT |
9 |
0.0038 |
| 127 |
THYROID HORMONES INCREASED |
4 |
0.0038 |
| 128 |
PHARYNGEAL PARAESTHESIA |
6 |
0.0038 |
| 129 |
BLOOD GLUCOSE FLUCTUATION |
41 |
0.0037 |
| 130 |
GALLBLADDER ENLARGEMENT |
4 |
0.0037 |
| 131 |
TONGUE DRY |
5 |
0.0037 |
| 132 |
PANCREATIC CYST |
7 |
0.0037 |
| 133 |
RADIOTHERAPY |
7 |
0.0037 |
| 134 |
PANCREATIC DISORDER |
18 |
0.0036 |
| 135 |
MALIGNANT NEOPLASM PROGRESSION |
371 |
0.0036 |
| 136 |
DEFAECATION URGENCY |
25 |
0.0036 |
| 137 |
SPLEEN DISORDER |
6 |
0.0035 |
| 138 |
BOWEL MOVEMENT IRREGULARITY |
27 |
0.0035 |
| 139 |
BRONCHIOLITIS |
12 |
0.0034 |
| 140 |
VITAMIN D DECREASED |
29 |
0.0034 |
| 141 |
COMPLEX REGIONAL PAIN SYNDROME |
5 |
0.0034 |
| 142 |
INDURATION |
6 |
0.0034 |
| 143 |
INTRA-ABDOMINAL FLUID COLLECTION |
6 |
0.0033 |
| 144 |
ABDOMINAL RIGIDITY |
9 |
0.0033 |
| 145 |
THYROID NEOPLASM |
9 |
0.0033 |
| 146 |
FAECES DISCOLOURED |
69 |
0.0032 |
| 147 |
HEPATOMEGALY |
31 |
0.0032 |
| 148 |
TONGUE BLISTERING |
7 |
0.0031 |
| 149 |
GASTROINTESTINAL HYPOMOTILITY |
7 |
0.0031 |
| 150 |
GASTROINTESTINAL PAIN |
34 |
0.0031 |
| 151 |
BLOOD GLUCOSE ABNORMAL |
57 |
0.0031 |
| 152 |
LIP INJURY |
4 |
0.0031 |
| 153 |
BLOOD PRESSURE DIASTOLIC INCREASED |
14 |
0.0030 |
| 154 |
GASTROINTESTINAL SOUNDS ABNORMAL |
15 |
0.0030 |
| 155 |
RHINALGIA |
8 |
0.0029 |
| 156 |
HEART RATE DECREASED |
101 |
0.0029 |
| 157 |
PRODUCT EXPIRATION DATE ISSUE |
4 |
0.0029 |
| 158 |
VERTIGO POSITIONAL |
5 |
0.0029 |
| 159 |
BLOOD ELECTROLYTES DECREASED |
4 |
0.0028 |
| 160 |
METASTASES TO LYMPH NODES |
19 |
0.0028 |
| 161 |
PROSTATOMEGALY |
11 |
0.0028 |
| 162 |
INJECTION SITE HYPOAESTHESIA |
4 |
0.0028 |
| 163 |
BLADDER SPASM |
5 |
0.0027 |
| 164 |
NEEDLE ISSUE |
77 |
0.0026 |
| 165 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
45 |
0.0026 |
| 166 |
ABDOMINAL DISTENSION |
273 |
0.0026 |
| 167 |
BLOOD IRON DECREASED |
31 |
0.0026 |
| 168 |
FAECES HARD |
10 |
0.0026 |
| 169 |
PRODUCT DEPOSIT |
4 |
0.0026 |
| 170 |
TEARFULNESS |
11 |
0.0026 |
| 171 |
RED BLOOD CELL COUNT INCREASED |
7 |
0.0025 |
| 172 |
CHAPPED LIPS |
11 |
0.0025 |
| 173 |
NODULE |
33 |
0.0025 |
| 174 |
METASTASIS |
18 |
0.0025 |
| 175 |
MASS |
35 |
0.0025 |
| 176 |
WEIGHT ABNORMAL |
6 |
0.0025 |
| 177 |
METASTASES TO BONE |
41 |
0.0025 |
| 178 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
4 |
0.0025 |
| 179 |
FREQUENT BOWEL MOVEMENTS |
67 |
0.0025 |
| 180 |
LIVER ABSCESS |
8 |
0.0025 |
| 181 |
ABDOMINAL PAIN |
573 |
0.0025 |
| 182 |
HAEMATOLOGICAL INFECTION |
6 |
0.0025 |
| 183 |
VITAMIN B12 DECREASED |
7 |
0.0024 |
| 184 |
GASTROINTESTINAL MOTILITY DISORDER |
13 |
0.0024 |
| 185 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
60 |
0.0024 |
| 186 |
RENAL PAIN |
25 |
0.0024 |
| 187 |
RENAL NEOPLASM |
5 |
0.0024 |
| 188 |
HEPATIC CYST |
8 |
0.0024 |
| 189 |
EXPOSURE TO SARS-COV-2 |
4 |
0.0024 |
| 190 |
CANCER PAIN |
6 |
0.0023 |
| 191 |
URINE ANALYSIS ABNORMAL |
7 |
0.0023 |
| 192 |
SYMPTOM RECURRENCE |
14 |
0.0023 |
| 193 |
METASTASES TO LUNG |
27 |
0.0023 |
| 194 |
BRAIN NEOPLASM |
21 |
0.0023 |
| 195 |
RESPIRATORY RATE INCREASED |
20 |
0.0023 |
| 196 |
DIARRHOEA |
1440 |
0.0022 |
| 197 |
BLOOD MAGNESIUM DECREASED |
19 |
0.0022 |
| 198 |
PERIARTHRITIS |
5 |
0.0022 |
| 199 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
40 |
0.0022 |
| 200 |
PANCREATITIS NECROTISING |
5 |
0.0022 |
| 201 |
FLUSHING |
219 |
0.0022 |
| 202 |
INTESTINAL OBSTRUCTION |
81 |
0.0021 |
| 203 |
HOSPICE CARE |
21 |
0.0021 |
| 204 |
NEAR DEATH EXPERIENCE |
7 |
0.0021 |
| 205 |
CORONAVIRUS INFECTION |
14 |
0.0021 |
| 206 |
HEART VALVE INCOMPETENCE |
6 |
0.0021 |
| 207 |
DIABETES INSIPIDUS |
5 |
0.0021 |
| 208 |
PULSE ABNORMAL |
5 |
0.0021 |
| 209 |
NEOPLASM RECURRENCE |
7 |
0.0021 |
| 210 |
BLOOD GLUCOSE DECREASED |
99 |
0.0021 |
| 211 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
4 |
0.0020 |
| 212 |
HYPOGLYCAEMIA |
99 |
0.0020 |
| 213 |
GALLBLADDER DISORDER |
36 |
0.0020 |
| 214 |
INFREQUENT BOWEL MOVEMENTS |
5 |
0.0020 |
| 215 |
METASTASES TO PERITONEUM |
5 |
0.0020 |
| 216 |
INJECTION SITE NECROSIS |
4 |
0.0020 |
| 217 |
INJECTION SITE PAIN |
601 |
0.0020 |
| 218 |
RENAL MASS |
4 |
0.0019 |
| 219 |
THYROID FUNCTION TEST ABNORMAL |
8 |
0.0019 |
| 220 |
MALABSORPTION |
10 |
0.0019 |
| 221 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
135 |
0.0019 |
| 222 |
EMOTIONAL DISORDER |
58 |
0.0019 |
| 223 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 224 |
MUSCULOSKELETAL CHEST PAIN |
29 |
0.0019 |
| 225 |
ASCITES |
55 |
0.0019 |
| 226 |
EXOPHTHALMOS |
4 |
0.0019 |
| 227 |
INJECTION SITE INDURATION |
24 |
0.0018 |
| 228 |
GROIN PAIN |
16 |
0.0018 |
| 229 |
MUCOUS STOOLS |
9 |
0.0018 |
| 230 |
MIDDLE EAR EFFUSION |
4 |
0.0018 |
| 231 |
PRODUCT LOT NUMBER ISSUE |
4 |
0.0018 |
| 232 |
SKIN MASS |
12 |
0.0018 |
| 233 |
SPINAL COLUMN INJURY |
4 |
0.0018 |
| 234 |
SPUTUM DISCOLOURED |
17 |
0.0018 |
| 235 |
DIABETIC COMA |
5 |
0.0018 |
| 236 |
BLOOD CALCIUM DECREASED |
20 |
0.0018 |
| 237 |
BLOOD CHOLESTEROL ABNORMAL |
8 |
0.0017 |
| 238 |
OFF LABEL USE |
1514 |
0.0017 |
| 239 |
PATELLA FRACTURE |
4 |
0.0017 |
| 240 |
ABDOMINAL PAIN LOWER |
43 |
0.0017 |
| 241 |
JAUNDICE CHOLESTATIC |
6 |
0.0017 |
| 242 |
TOXIC SKIN ERUPTION |
17 |
0.0017 |
| 243 |
INTERCEPTED PRODUCT STORAGE ERROR |
6 |
0.0017 |
| 244 |
NEPHROLITHIASIS |
77 |
0.0017 |
| 245 |
CHOLECYSTECTOMY |
19 |
0.0017 |
| 246 |
ERUCTATION |
32 |
0.0017 |
| 247 |
DIZZINESS POSTURAL |
16 |
0.0016 |
| 248 |
BLOOD SODIUM DECREASED |
31 |
0.0016 |
| 249 |
DIABETES MELLITUS INADEQUATE CONTROL |
29 |
0.0016 |
| 250 |
DYSCHEZIA |
5 |
0.0016 |
| 251 |
ASTHENOPIA |
9 |
0.0016 |
| 252 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
9 |
0.0016 |
| 253 |
PRODUCT LEAKAGE |
9 |
0.0016 |
| 254 |
FLANK PAIN |
15 |
0.0016 |
| 255 |
BLOOD POTASSIUM DECREASED |
48 |
0.0016 |
| 256 |
BLOOD CALCIUM INCREASED |
14 |
0.0016 |
| 257 |
COLD SWEAT |
28 |
0.0016 |
| 258 |
URINARY TRACT INFECTION BACTERIAL |
4 |
0.0016 |
| 259 |
LABYRINTHITIS |
4 |
0.0016 |
| 260 |
ABDOMINAL DISCOMFORT |
265 |
0.0016 |
| 261 |
CARDIAC VALVE DISEASE |
9 |
0.0016 |
| 262 |
THERAPEUTIC PRODUCT INEFFECTIVE |
6 |
0.0016 |
| 263 |
LIPOMA |
4 |
0.0015 |
| 264 |
ABDOMINAL PAIN UPPER |
317 |
0.0015 |
| 265 |
URINE OUTPUT INCREASED |
4 |
0.0015 |
| 266 |
PERSONALITY DISORDER |
4 |
0.0015 |
| 267 |
BODY TEMPERATURE DECREASED |
15 |
0.0015 |
| 268 |
LOCALISED OEDEMA |
7 |
0.0015 |
| 269 |
CHOLECYSTITIS |
18 |
0.0015 |
| 270 |
HAEMORRHOIDS |
29 |
0.0015 |
| 271 |
DEATH |
1278 |
0.0015 |
| 272 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
71 |
0.0015 |
| 273 |
WEIGHT DECREASED |
409 |
0.0015 |
| 274 |
REGURGITATION |
5 |
0.0015 |
| 275 |
THIRST |
26 |
0.0015 |
| 276 |
MUSCULOSKELETAL DISCOMFORT |
25 |
0.0015 |
| 277 |
CHOLANGITIS |
9 |
0.0015 |
| 278 |
BLOOD PRESSURE SYSTOLIC INCREASED |
28 |
0.0014 |
| 279 |
TRICHORRHEXIS |
4 |
0.0014 |
| 280 |
BLOOD TEST ABNORMAL |
20 |
0.0014 |
| 281 |
CEREBRAL THROMBOSIS |
4 |
0.0014 |
| 282 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
254 |
0.0014 |
| 283 |
EATING DISORDER |
30 |
0.0014 |
| 284 |
BLOOD PRESSURE ABNORMAL |
28 |
0.0014 |
| 285 |
ABSCESS LIMB |
6 |
0.0014 |
| 286 |
TUMOUR HAEMORRHAGE |
4 |
0.0014 |
| 287 |
HYPERGLYCAEMIA |
51 |
0.0014 |
| 288 |
HOSPITALISATION |
214 |
0.0014 |
| 289 |
CONSTIPATION |
303 |
0.0014 |
| 290 |
RENAL CYST |
11 |
0.0014 |
| 291 |
DYSPNOEA AT REST |
4 |
0.0014 |
| 292 |
ESCHERICHIA SEPSIS |
4 |
0.0014 |
| 293 |
BONE CANCER |
6 |
0.0014 |
| 294 |
LIVER DISORDER |
61 |
0.0014 |
| 295 |
HAEMATOTOXICITY |
13 |
0.0014 |
| 296 |
FOOD INTOLERANCE |
5 |
0.0014 |
| 297 |
INJECTION SITE HAEMORRHAGE |
109 |
0.0014 |
| 298 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
7 |
0.0014 |
| 299 |
CACHEXIA |
7 |
0.0014 |
| 300 |
GINGIVAL SWELLING |
6 |
0.0014 |
| 301 |
TEMPERATURE INTOLERANCE |
14 |
0.0014 |
| 302 |
DENTAL CARIES |
15 |
0.0014 |
| 303 |
PSYCHIATRIC SYMPTOM |
10 |
0.0014 |
| 304 |
AFFECT LABILITY |
13 |
0.0013 |
| 305 |
DISEASE PROGRESSION |
159 |
0.0013 |
| 306 |
MALNUTRITION |
15 |
0.0013 |
| 307 |
METABOLIC ENCEPHALOPATHY |
4 |
0.0013 |
| 308 |
FULL BLOOD COUNT ABNORMAL |
14 |
0.0013 |
| 309 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
6 |
0.0013 |
| 310 |
PRODUCT DOSE OMISSION ISSUE |
388 |
0.0013 |
| 311 |
FACE INJURY |
5 |
0.0013 |
| 312 |
ANORECTAL DISCOMFORT |
7 |
0.0013 |
| 313 |
BLOOD TESTOSTERONE DECREASED |
9 |
0.0013 |
| 314 |
HOT FLUSH |
99 |
0.0013 |
| 315 |
ONYCHOCLASIS |
9 |
0.0013 |
| 316 |
THYROID MASS |
5 |
0.0013 |
| 317 |
SMALL INTESTINAL OBSTRUCTION |
16 |
0.0013 |
| 318 |
FEEDING DISORDER |
26 |
0.0013 |
| 319 |
EPIGASTRIC DISCOMFORT |
5 |
0.0013 |
| 320 |
BODY TEMPERATURE INCREASED |
26 |
0.0013 |
| 321 |
SWELLING OF EYELID |
8 |
0.0013 |
| 322 |
FATIGUE |
983 |
0.0013 |
| 323 |
SCIATICA |
20 |
0.0013 |
| 324 |
HEART RATE IRREGULAR |
28 |
0.0012 |
| 325 |
PORTAL VEIN THROMBOSIS |
4 |
0.0012 |
| 326 |
CHOLECYSTITIS ACUTE |
7 |
0.0012 |
| 327 |
HEPATIC STEATOSIS |
23 |
0.0012 |
| 328 |
LIQUID PRODUCT PHYSICAL ISSUE |
9 |
0.0012 |
| 329 |
PRESYNCOPE |
30 |
0.0012 |
| 330 |
THYROID DISORDER |
19 |
0.0012 |
| 331 |
DEPRESSED MOOD |
65 |
0.0012 |
| 332 |
DECUBITUS ULCER |
10 |
0.0012 |
| 333 |
BRADYCARDIA |
65 |
0.0012 |
| 334 |
ANAL INCONTINENCE |
11 |
0.0012 |
| 335 |
GOITRE |
5 |
0.0012 |
| 336 |
INJECTION SITE INFECTION |
4 |
0.0012 |
| 337 |
SARS-COV-2 TEST POSITIVE |
16 |
0.0012 |
| 338 |
BLOOD GLUCOSE INCREASED |
228 |
0.0012 |
| 339 |
DECREASED APPETITE |
280 |
0.0012 |
| 340 |
METABOLIC DISORDER |
7 |
0.0012 |
| 341 |
INJECTION SITE INFLAMMATION |
6 |
0.0012 |
| 342 |
SKIN LACERATION |
13 |
0.0012 |
| 343 |
INJECTION SITE PRURITUS |
80 |
0.0012 |
| 344 |
NERVE COMPRESSION |
11 |
0.0012 |
| 345 |
GASTROINTESTINAL DISORDER |
106 |
0.0012 |
| 346 |
TASTE DISORDER |
24 |
0.0012 |
| 347 |
TONGUE DISCOMFORT |
5 |
0.0012 |
| 348 |
PERIPHERAL COLDNESS |
16 |
0.0012 |
| 349 |
MUSCLE STRAIN |
10 |
0.0012 |
| 350 |
ALOPECIA |
226 |
0.0011 |
| 351 |
BEDRIDDEN |
15 |
0.0011 |
| 352 |
ATELECTASIS |
11 |
0.0011 |
| 353 |
BLOOD PRESSURE INCREASED |
174 |
0.0011 |
| 354 |
HYPOTHYROIDISM |
36 |
0.0011 |
| 355 |
BLOOD DISORDER |
9 |
0.0011 |
| 356 |
GASTROINTESTINAL INFECTION |
10 |
0.0011 |
| 357 |
ASTHENIA |
418 |
0.0011 |
| 358 |
SUSPECTED OFF LABEL USE |
5 |
0.0011 |
| 359 |
BLOOD URINE PRESENT |
21 |
0.0011 |
| 360 |
HYPERTENSION |
234 |
0.0011 |
| 361 |
SLEEP APNOEA SYNDROME |
21 |
0.0011 |
| 362 |
POLYURIA |
9 |
0.0011 |
| 363 |
INCREASED APPETITE |
21 |
0.0011 |
| 364 |
FAECALOMA |
6 |
0.0011 |
| 365 |
UTERINE LEIOMYOMA |
8 |
0.0011 |
| 366 |
POST PROCEDURAL COMPLICATION |
21 |
0.0011 |
| 367 |
ILLNESS |
112 |
0.0011 |
| 368 |
LABORATORY TEST ABNORMAL |
32 |
0.0011 |
| 369 |
PRODUCT USE COMPLAINT |
17 |
0.0011 |
| 370 |
FEELING COLD |
30 |
0.0011 |
| 371 |
HEART RATE ABNORMAL |
6 |
0.0011 |
| 372 |
YELLOW SKIN |
5 |
0.0011 |
| 373 |
CHEMOTHERAPY |
4 |
0.0011 |
| 374 |
TUMOUR MARKER INCREASED |
5 |
0.0010 |
| 375 |
BLOOD PRESSURE FLUCTUATION |
25 |
0.0010 |
| 376 |
PRODUCT ADMINISTRATION ERROR |
21 |
0.0010 |
| 377 |
DIABETES MELLITUS |
79 |
0.0010 |
| 378 |
CONCUSSION |
8 |
0.0010 |
| 379 |
FINGER DEFORMITY |
5 |
0.0010 |
| 380 |
HAEMORRHOIDAL HAEMORRHAGE |
5 |
0.0010 |
| 381 |
FEELING OF BODY TEMPERATURE CHANGE |
6 |
0.0010 |
| 382 |
NAIL DISCOLOURATION |
4 |
0.0010 |
| 383 |
MALAISE |
446 |
0.0010 |
| 384 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 385 |
EXTRASYSTOLES |
7 |
0.0010 |
| 386 |
FUNGAL SKIN INFECTION |
4 |
0.0010 |
| 387 |
FRUSTRATION TOLERANCE DECREASED |
8 |
0.0010 |
| 388 |
RECURRENT CANCER |
4 |
0.0010 |
| 389 |
CONTUSION |
94 |
0.0010 |
| 390 |
SELF-MEDICATION |
4 |
0.0010 |
| 391 |
SYNCOPE |
97 |
0.0010 |
| 392 |
DISCOMFORT |
59 |
0.0010 |
| 393 |
HYPOKINESIA |
14 |
0.0010 |
| 394 |
HEAD DISCOMFORT |
17 |
0.0010 |
| 395 |
TENDERNESS |
10 |
0.0010 |
| 396 |
LIMB INJURY |
26 |
0.0010 |
| 397 |
IMPAIRED GASTRIC EMPTYING |
13 |
0.0010 |
| 398 |
SPINAL DISORDER |
9 |
0.0009 |
| 399 |
SENSITIVE SKIN |
7 |
0.0009 |
| 400 |
DEVICE MECHANICAL ISSUE |
13 |
0.0009 |
| 401 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 402 |
HYPERSOMNIA |
27 |
0.0009 |
| 403 |
AORTIC VALVE INCOMPETENCE |
4 |
0.0009 |
| 404 |
HEART RATE INCREASED |
93 |
0.0009 |
| 405 |
LETHARGY |
54 |
0.0009 |
| 406 |
BACK PAIN |
218 |
0.0009 |
| 407 |
DEHYDRATION |
125 |
0.0009 |
| 408 |
LUNG NEOPLASM |
4 |
0.0009 |
| 409 |
NAUSEA |
735 |
0.0009 |
| 410 |
METASTATIC NEOPLASM |
4 |
0.0009 |
| 411 |
HORDEOLUM |
4 |
0.0009 |
| 412 |
NERVOUSNESS |
48 |
0.0009 |
| 413 |
PALLOR |
25 |
0.0009 |
| 414 |
HEAD INJURY |
29 |
0.0009 |
| 415 |
DIVERTICULUM INTESTINAL |
4 |
0.0009 |
| 416 |
SYRINGE ISSUE |
16 |
0.0009 |
| 417 |
NOCTURIA |
11 |
0.0009 |
| 418 |
APPETITE DISORDER |
6 |
0.0009 |
| 419 |
LOW DENSITY LIPOPROTEIN INCREASED |
7 |
0.0009 |
| 420 |
INJECTION SITE INJURY |
5 |
0.0009 |
| 421 |
NERVE INJURY |
10 |
0.0009 |
| 422 |
PELVIC FRACTURE |
7 |
0.0009 |
| 423 |
THERAPY PARTIAL RESPONDER |
14 |
0.0009 |
| 424 |
BREAST MASS |
6 |
0.0009 |
| 425 |
IRON DEFICIENCY |
4 |
0.0009 |
| 426 |
PERIPHERAL SWELLING |
137 |
0.0009 |
| 427 |
PNEUMOTHORAX |
14 |
0.0009 |
| 428 |
SLUGGISHNESS |
9 |
0.0009 |
| 429 |
TRICUSPID VALVE INCOMPETENCE |
7 |
0.0009 |
| 430 |
BLOOD PRESSURE SYSTOLIC DECREASED |
4 |
0.0009 |
| 431 |
DRUG EFFECT LESS THAN EXPECTED |
13 |
0.0009 |
| 432 |
HAEMOGLOBIN INCREASED |
4 |
0.0009 |
| 433 |
LOSS OF CONSCIOUSNESS |
112 |
0.0009 |
| 434 |
DYSPEPSIA |
86 |
0.0009 |
| 435 |
IMMUNE THROMBOCYTOPENIA |
4 |
0.0009 |
| 436 |
POLLAKIURIA |
36 |
0.0009 |
| 437 |
RALES |
5 |
0.0009 |
| 438 |
DYSPNOEA EXERTIONAL |
32 |
0.0008 |
| 439 |
BLOOD PROLACTIN INCREASED |
4 |
0.0008 |
| 440 |
DECREASED INTEREST |
5 |
0.0008 |
| 441 |
LYMPHADENOPATHY |
30 |
0.0008 |
| 442 |
ENERGY INCREASED |
5 |
0.0008 |
| 443 |
SKIN ABRASION |
4 |
0.0008 |
| 444 |
DIZZINESS |
422 |
0.0008 |
| 445 |
GASTRIC ULCER |
16 |
0.0008 |
| 446 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
30 |
0.0008 |
| 447 |
OEDEMA PERIPHERAL |
102 |
0.0008 |
| 448 |
SURGERY |
49 |
0.0008 |
| 449 |
CHOLESTASIS |
16 |
0.0008 |
| 450 |
TYPE 2 DIABETES MELLITUS |
28 |
0.0008 |
| 451 |
GENERAL PHYSICAL HEALTH DETERIORATION |
96 |
0.0008 |
| 452 |
WOUND |
23 |
0.0008 |
| 453 |
QUALITY OF LIFE DECREASED |
11 |
0.0008 |
| 454 |
INJECTION SITE EXTRAVASATION |
10 |
0.0008 |
| 455 |
HEADACHE |
507 |
0.0008 |
| 456 |
PYELONEPHRITIS |
7 |
0.0008 |
| 457 |
HYPERHIDROSIS |
104 |
0.0008 |
| 458 |
CYST |
10 |
0.0008 |
| 459 |
ANEURYSM |
4 |
0.0008 |
| 460 |
INJECTION SITE DISCOLOURATION |
10 |
0.0008 |
| 461 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 462 |
PANCREATITIS |
42 |
0.0008 |
| 463 |
OEDEMA |
43 |
0.0008 |
| 464 |
PHOTOPSIA |
5 |
0.0008 |
| 465 |
VOMITING |
371 |
0.0008 |
| 466 |
MICTURITION URGENCY |
9 |
0.0008 |
| 467 |
DRY THROAT |
8 |
0.0008 |
| 468 |
AMMONIA INCREASED |
4 |
0.0008 |
| 469 |
BLOOD PRESSURE DECREASED |
52 |
0.0008 |
| 470 |
NIGHT SWEATS |
25 |
0.0008 |
| 471 |
GASTROENTERITIS VIRAL |
14 |
0.0008 |
| 472 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 473 |
MOOD ALTERED |
21 |
0.0008 |
| 474 |
PETECHIAE |
8 |
0.0008 |
| 475 |
BRAIN FOG |
12 |
0.0008 |
| 476 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
8 |
0.0008 |
| 477 |
INCONTINENCE |
8 |
0.0008 |
| 478 |
HYPOTENSION |
151 |
0.0008 |
| 479 |
RENAL DISORDER |
35 |
0.0008 |
| 480 |
WRIST FRACTURE |
9 |
0.0008 |
| 481 |
HAEMATEMESIS |
19 |
0.0007 |
| 482 |
FOOD POISONING |
4 |
0.0007 |
| 483 |
PRODUCT AVAILABILITY ISSUE |
17 |
0.0007 |
| 484 |
MUSCLE SPASMS |
137 |
0.0007 |
| 485 |
IRRITABLE BOWEL SYNDROME |
16 |
0.0007 |
| 486 |
ANAL FISSURE |
4 |
0.0007 |
| 487 |
INTESTINAL RESECTION |
4 |
0.0007 |
| 488 |
SINUS CONGESTION |
10 |
0.0007 |
| 489 |
HIP SURGERY |
4 |
0.0007 |
| 490 |
COVID-19 |
129 |
0.0007 |
| 491 |
DYSPHONIA |
43 |
0.0007 |
| 492 |
BONE PAIN |
43 |
0.0007 |
| 493 |
ABNORMAL LOSS OF WEIGHT |
5 |
0.0007 |
| 494 |
INTERVERTEBRAL DISC PROTRUSION |
16 |
0.0007 |
| 495 |
RIB FRACTURE |
15 |
0.0007 |
| 496 |
TOOTH FRACTURE |
8 |
0.0007 |
| 497 |
MUSCULOSKELETAL PAIN |
38 |
0.0007 |
| 498 |
PLEURAL EFFUSION |
44 |
0.0007 |
| 499 |
LIVER FUNCTION TEST ABNORMAL |
21 |
0.0007 |
| 500 |
DIVERTICULITIS |
20 |
0.0007 |
| 501 |
PRODUCT DOSE OMISSION |
47 |
0.0007 |
| 502 |
TOOTHACHE |
13 |
0.0007 |
| 503 |
ORAL PAIN |
16 |
0.0007 |
| 504 |
CARPAL TUNNEL SYNDROME |
10 |
0.0007 |
| 505 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 506 |
LIGAMENT SPRAIN |
7 |
0.0007 |
| 507 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
12 |
0.0007 |
| 508 |
ADVERSE EVENT |
65 |
0.0007 |
| 509 |
DIVERTICULUM |
5 |
0.0007 |
| 510 |
DRY MOUTH |
57 |
0.0007 |
| 511 |
SPINAL FRACTURE |
14 |
0.0007 |
| 512 |
CARDIAC OPERATION |
6 |
0.0007 |
| 513 |
HERPES VIRUS INFECTION |
4 |
0.0007 |
| 514 |
THERAPEUTIC RESPONSE SHORTENED |
23 |
0.0007 |
| 515 |
HYSTERECTOMY |
6 |
0.0007 |
| 516 |
URINARY TRACT INFECTION |
118 |
0.0007 |
| 517 |
ELECTROLYTE IMBALANCE |
8 |
0.0007 |
| 518 |
NAIL DISORDER |
6 |
0.0007 |
| 519 |
APATHY |
10 |
0.0007 |
| 520 |
FEELING HOT |
42 |
0.0007 |
| 521 |
WEIGHT INCREASED |
153 |
0.0007 |
| 522 |
MYALGIA |
116 |
0.0007 |
| 523 |
AGEUSIA |
17 |
0.0007 |
| 524 |
CHEST PAIN |
126 |
0.0007 |
| 525 |
DEMENTIA |
19 |
0.0007 |
| 526 |
CEREBRAL DISORDER |
5 |
0.0007 |
| 527 |
CARDIAC DISORDER |
63 |
0.0007 |
| 528 |
HERNIA |
13 |
0.0007 |
| 529 |
HYPOKALAEMIA |
31 |
0.0007 |
| 530 |
GENERAL SYMPTOM |
5 |
0.0007 |
| 531 |
ARTHRALGIA |
277 |
0.0007 |
| 532 |
HYPOPHAGIA |
17 |
0.0007 |
| 533 |
PAROSMIA |
5 |
0.0007 |
| 534 |
FALL |
220 |
0.0007 |
| 535 |
NEOPLASM MALIGNANT |
44 |
0.0007 |
| 536 |
BONE DISORDER |
12 |
0.0007 |
| 537 |
BLOOD UREA INCREASED |
11 |
0.0007 |
| 538 |
TENSION |
4 |
0.0007 |
| 539 |
CATARACT |
39 |
0.0007 |
| 540 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
6 |
0.0007 |
| 541 |
DRUG ABUSER |
4 |
0.0007 |
| 542 |
DYSSTASIA |
19 |
0.0007 |
| 543 |
MENISCUS INJURY |
4 |
0.0006 |
| 544 |
PAIN |
399 |
0.0006 |
| 545 |
CHILLS |
76 |
0.0006 |
| 546 |
CONCOMITANT DISEASE AGGRAVATED |
4 |
0.0006 |
| 547 |
ATRIOVENTRICULAR BLOCK |
5 |
0.0006 |
| 548 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
14 |
0.0006 |
| 549 |
PRODUCT PRESCRIBING ISSUE |
14 |
0.0006 |
| 550 |
DEVICE OCCLUSION |
9 |
0.0006 |
| 551 |
GASTROINTESTINAL INFLAMMATION |
5 |
0.0006 |
| 552 |
LOWER RESPIRATORY TRACT INFECTION |
29 |
0.0006 |
| 553 |
CYANOSIS |
10 |
0.0006 |
| 554 |
SEASONAL ALLERGY |
9 |
0.0006 |
| 555 |
ARRHYTHMIA |
30 |
0.0006 |
| 556 |
PRODUCT PACKAGING ISSUE |
6 |
0.0006 |
| 557 |
RED BLOOD CELL COUNT DECREASED |
18 |
0.0006 |
| 558 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 559 |
HEPATIC CANCER |
15 |
0.0006 |
| 560 |
SLEEP DISORDER |
44 |
0.0006 |
| 561 |
ANGER |
21 |
0.0006 |
| 562 |
EYE INFECTION |
7 |
0.0006 |
| 563 |
FEELING ABNORMAL |
148 |
0.0006 |
| 564 |
HEPATIC ENZYME INCREASED |
42 |
0.0006 |
| 565 |
HAEMATOCHEZIA |
34 |
0.0006 |
| 566 |
BLOOD POTASSIUM INCREASED |
10 |
0.0006 |
| 567 |
GOUT |
11 |
0.0006 |
| 568 |
PROCEDURAL PAIN |
17 |
0.0006 |
| 569 |
GASTRITIS |
16 |
0.0006 |
| 570 |
UNEVALUABLE EVENT |
46 |
0.0006 |
| 571 |
DYSGRAPHIA |
4 |
0.0006 |
| 572 |
VERTIGO |
37 |
0.0006 |
| 573 |
PULMONARY MASS |
9 |
0.0006 |
| 574 |
UPPER LIMB FRACTURE |
12 |
0.0006 |
| 575 |
MOOD SWINGS |
19 |
0.0006 |
| 576 |
BLOOD BILIRUBIN INCREASED |
16 |
0.0006 |
| 577 |
PAIN IN EXTREMITY |
174 |
0.0006 |
| 578 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 579 |
ANKLE FRACTURE |
9 |
0.0006 |
| 580 |
MYOPATHY |
5 |
0.0006 |
| 581 |
HAIR GROWTH ABNORMAL |
4 |
0.0006 |
| 582 |
LARGE INTESTINE POLYP |
4 |
0.0006 |
| 583 |
BURSITIS |
7 |
0.0006 |
| 584 |
ADRENAL INSUFFICIENCY |
7 |
0.0006 |
| 585 |
ANXIETY |
163 |
0.0006 |
| 586 |
TRANSFUSION |
6 |
0.0006 |
| 587 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0006 |
| 588 |
CARDIOMEGALY |
7 |
0.0006 |
| 589 |
SKIN DISCOLOURATION |
26 |
0.0006 |
| 590 |
PRODUCTIVE COUGH |
27 |
0.0006 |
| 591 |
CYSTITIS |
18 |
0.0006 |
| 592 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
14 |
0.0006 |
| 593 |
ORAL HERPES |
11 |
0.0006 |
| 594 |
FEAR OF INJECTION |
4 |
0.0006 |
| 595 |
RECTAL HAEMORRHAGE |
24 |
0.0006 |
| 596 |
ANGINA PECTORIS |
16 |
0.0006 |
| 597 |
ADVERSE DRUG REACTION |
50 |
0.0006 |
| 598 |
HAEMOGLOBIN DECREASED |
57 |
0.0006 |
| 599 |
PANCREATIC CARCINOMA |
16 |
0.0006 |
| 600 |
HYPERTHYROIDISM |
8 |
0.0006 |
| 601 |
COMPLICATION ASSOCIATED WITH DEVICE |
8 |
0.0006 |
| 602 |
GASTROENTERITIS |
8 |
0.0005 |
| 603 |
GASTROOESOPHAGEAL REFLUX DISEASE |
44 |
0.0005 |
| 604 |
IRON DEFICIENCY ANAEMIA |
5 |
0.0005 |
| 605 |
INTERVERTEBRAL DISC DEGENERATION |
5 |
0.0005 |
| 606 |
PRODUCT DISTRIBUTION ISSUE |
5 |
0.0005 |
| 607 |
PALPITATIONS |
63 |
0.0005 |
| 608 |
SUNBURN |
4 |
0.0005 |
| 609 |
BLOOD CHOLESTEROL INCREASED |
25 |
0.0005 |
| 610 |
INJECTION SITE SWELLING |
41 |
0.0005 |
| 611 |
SKIN INFECTION |
6 |
0.0005 |
| 612 |
INJECTION SITE WARMTH |
11 |
0.0005 |
| 613 |
INFLUENZA LIKE ILLNESS |
44 |
0.0005 |
| 614 |
OXYGEN SATURATION DECREASED |
30 |
0.0005 |
| 615 |
CIRCULATORY COLLAPSE |
9 |
0.0005 |
| 616 |
HYPOCALCAEMIA |
10 |
0.0005 |
| 617 |
TENDON PAIN |
4 |
0.0005 |
| 618 |
SCAR |
9 |
0.0005 |
| 619 |
INTERNAL HAEMORRHAGE |
6 |
0.0005 |
| 620 |
GAIT DISTURBANCE |
100 |
0.0005 |
| 621 |
BLOOD CREATININE INCREASED |
34 |
0.0005 |
| 622 |
JAUNDICE |
14 |
0.0005 |
| 623 |
OROPHARYNGEAL PAIN |
48 |
0.0005 |
| 624 |
PRESCRIBED OVERDOSE |
10 |
0.0005 |
| 625 |
APHTHOUS ULCER |
4 |
0.0005 |
| 626 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 627 |
LIVER FUNCTION TEST INCREASED |
11 |
0.0005 |
| 628 |
SPINAL PAIN |
6 |
0.0005 |
| 629 |
MUSCULAR WEAKNESS |
58 |
0.0005 |
| 630 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 631 |
KIDNEY INFECTION |
10 |
0.0005 |
| 632 |
CENTRAL NERVOUS SYSTEM LESION |
7 |
0.0005 |
| 633 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 634 |
TACHYCARDIA |
45 |
0.0005 |
| 635 |
HAEMATOCRIT DECREASED |
10 |
0.0005 |
| 636 |
ACCIDENT |
6 |
0.0005 |
| 637 |
INFLUENZA |
56 |
0.0005 |
| 638 |
ABSCESS |
8 |
0.0005 |
| 639 |
NECK PAIN |
28 |
0.0005 |
| 640 |
TINNITUS |
23 |
0.0005 |
| 641 |
OVARIAN CYST |
5 |
0.0005 |
| 642 |
THYROID CANCER |
6 |
0.0005 |
| 643 |
RHINITIS |
4 |
0.0005 |
| 644 |
ARTHRITIS |
39 |
0.0005 |
| 645 |
OSTEOARTHRITIS |
21 |
0.0005 |
| 646 |
MUSCLE TIGHTNESS |
8 |
0.0005 |
| 647 |
FIBROMYALGIA |
12 |
0.0005 |
| 648 |
POST PROCEDURAL INFECTION |
4 |
0.0005 |
| 649 |
FLUID RETENTION |
25 |
0.0005 |
| 650 |
ESCHERICHIA INFECTION |
4 |
0.0005 |
| 651 |
HYPERCALCAEMIA |
6 |
0.0005 |
| 652 |
DRUG DOSE OMISSION BY DEVICE |
38 |
0.0005 |
| 653 |
INSOMNIA |
129 |
0.0005 |
| 654 |
MYELODYSPLASTIC SYNDROME |
7 |
0.0005 |
| 655 |
NASOPHARYNGITIS |
89 |
0.0005 |
| 656 |
TOOTH EXTRACTION |
6 |
0.0005 |
| 657 |
EMBOLISM |
4 |
0.0005 |
| 658 |
VIRAL INFECTION |
16 |
0.0005 |
| 659 |
SECRETION DISCHARGE |
6 |
0.0005 |
| 660 |
GAIT INABILITY |
16 |
0.0005 |
| 661 |
STOMATITIS |
29 |
0.0005 |
| 662 |
FOOT FRACTURE |
9 |
0.0005 |
| 663 |
INJECTION SITE IRRITATION |
6 |
0.0005 |
| 664 |
MIGRAINE |
45 |
0.0005 |
| 665 |
HEPATIC CYTOLYSIS |
6 |
0.0005 |
| 666 |
DEPRESSION |
107 |
0.0005 |
| 667 |
BREAST PAIN |
5 |
0.0005 |
| 668 |
JOINT INJURY |
10 |
0.0005 |
| 669 |
BODY HEIGHT DECREASED |
5 |
0.0005 |
| 670 |
ROTATOR CUFF SYNDROME |
6 |
0.0005 |
| 671 |
PRODUCT CONTAINER ISSUE |
4 |
0.0005 |
| 672 |
POOR QUALITY SLEEP |
10 |
0.0005 |
| 673 |
INJECTION SITE BRUISING |
37 |
0.0005 |
| 674 |
BACK INJURY |
5 |
0.0005 |
| 675 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 676 |
INCORRECT PRODUCT STORAGE |
6 |
0.0005 |
| 677 |
WOUND INFECTION |
5 |
0.0005 |
| 678 |
ORAL CANDIDIASIS |
6 |
0.0005 |
| 679 |
WHEEZING |
27 |
0.0005 |
| 680 |
IMMUNE SYSTEM DISORDER |
6 |
0.0005 |
| 681 |
TOOTH INFECTION |
6 |
0.0005 |
| 682 |
DEVICE RELATED INFECTION |
7 |
0.0005 |
| 683 |
TENDONITIS |
7 |
0.0005 |
| 684 |
FOOT DEFORMITY |
5 |
0.0005 |
| 685 |
DYSPNOEA |
255 |
0.0005 |
| 686 |
TOOTH DISORDER |
10 |
0.0004 |
| 687 |
LIVER INJURY |
11 |
0.0004 |
| 688 |
PANCREATITIS ACUTE |
10 |
0.0004 |
| 689 |
HEAVY MENSTRUAL BLEEDING |
4 |
0.0004 |
| 690 |
OROPHARYNGEAL DISCOMFORT |
4 |
0.0004 |
| 691 |
NASAL CONGESTION |
26 |
0.0004 |
| 692 |
BALANCE DISORDER |
38 |
0.0004 |
| 693 |
GINGIVAL BLEEDING |
6 |
0.0004 |
| 694 |
PYREXIA |
152 |
0.0004 |
| 695 |
SCAB |
5 |
0.0004 |
| 696 |
EXOSTOSIS |
4 |
0.0004 |
| 697 |
OSTEOPOROSIS |
18 |
0.0004 |
| 698 |
CARDIAC FAILURE |
35 |
0.0004 |
| 699 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
31 |
0.0004 |
| 700 |
COUGH |
122 |
0.0004 |
| 701 |
DYSURIA |
16 |
0.0004 |
| 702 |
HYPOAESTHESIA |
65 |
0.0004 |
| 703 |
OVARIAN CANCER |
4 |
0.0004 |
| 704 |
HEPATIC FAILURE |
13 |
0.0004 |
| 705 |
JOINT SWELLING |
52 |
0.0004 |
| 706 |
LACRIMATION INCREASED |
13 |
0.0004 |
| 707 |
COORDINATION ABNORMAL |
6 |
0.0004 |
| 708 |
APHONIA |
6 |
0.0004 |
| 709 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0004 |
| 710 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
10 |
0.0004 |
| 711 |
BACTERIAL INFECTION |
8 |
0.0004 |
| 712 |
RENAL IMPAIRMENT |
36 |
0.0004 |
| 713 |
DISTURBANCE IN ATTENTION |
23 |
0.0004 |
| 714 |
LYMPHOPENIA |
6 |
0.0004 |
| 715 |
THROMBOSIS |
34 |
0.0004 |
| 716 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 717 |
MOBILITY DECREASED |
30 |
0.0004 |
| 718 |
AMNESIA |
27 |
0.0004 |
| 719 |
CANDIDA INFECTION |
7 |
0.0004 |
| 720 |
CONDITION AGGRAVATED |
126 |
0.0004 |
| 721 |
EAR INFECTION |
11 |
0.0004 |
| 722 |
CRYING |
15 |
0.0004 |
| 723 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 724 |
DRUG EFFECT DECREASED |
22 |
0.0004 |
| 725 |
INFECTION |
59 |
0.0004 |
| 726 |
SWELLING |
38 |
0.0004 |
| 727 |
HIP FRACTURE |
13 |
0.0004 |
| 728 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 729 |
ANAEMIA |
77 |
0.0004 |
| 730 |
ORTHOSTATIC HYPOTENSION |
7 |
0.0004 |
| 731 |
DEVICE DELIVERY SYSTEM ISSUE |
11 |
0.0004 |
| 732 |
CHEST DISCOMFORT |
41 |
0.0004 |
| 733 |
IRRITABILITY |
24 |
0.0004 |
| 734 |
HYPOXIA |
14 |
0.0004 |
| 735 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
80 |
0.0004 |
| 736 |
HAEMOPTYSIS |
11 |
0.0004 |
| 737 |
VISION BLURRED |
54 |
0.0004 |
| 738 |
TOOTH ABSCESS |
4 |
0.0004 |
| 739 |
URINARY RETENTION |
13 |
0.0004 |
| 740 |
PRODUCT DOSE OMISSION IN ERROR |
11 |
0.0004 |
| 741 |
UNRESPONSIVE TO STIMULI |
10 |
0.0004 |
| 742 |
MEMORY IMPAIRMENT |
53 |
0.0004 |
| 743 |
TREMOR |
64 |
0.0004 |
| 744 |
PELVIC PAIN |
7 |
0.0004 |
| 745 |
RESTLESS LEGS SYNDROME |
7 |
0.0004 |
| 746 |
SWOLLEN TONGUE |
12 |
0.0004 |
| 747 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
10 |
0.0004 |
| 748 |
JOINT STIFFNESS |
10 |
0.0004 |
| 749 |
MOUTH ULCERATION |
8 |
0.0004 |
| 750 |
ABNORMAL BEHAVIOUR |
15 |
0.0004 |
| 751 |
CONFUSIONAL STATE |
61 |
0.0004 |
| 752 |
SEPSIS |
42 |
0.0004 |
| 753 |
EYE SWELLING |
14 |
0.0004 |
| 754 |
EYE HAEMORRHAGE |
5 |
0.0004 |
| 755 |
SENSORY DISTURBANCE |
6 |
0.0004 |
| 756 |
RHINORRHOEA |
24 |
0.0004 |
| 757 |
URINARY INCONTINENCE |
11 |
0.0004 |
| 758 |
VISUAL IMPAIRMENT |
46 |
0.0004 |
| 759 |
HYPERKALAEMIA |
13 |
0.0004 |
| 760 |
FRACTURE |
7 |
0.0004 |
| 761 |
BIPOLAR DISORDER |
4 |
0.0004 |
| 762 |
SOMNOLENCE |
74 |
0.0004 |
| 763 |
PNEUMONITIS |
10 |
0.0004 |
| 764 |
DRY SKIN |
49 |
0.0004 |
| 765 |
INTENTIONAL PRODUCT MISUSE |
32 |
0.0004 |
| 766 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
5 |
0.0004 |
| 767 |
EAR PAIN |
7 |
0.0004 |
| 768 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 769 |
HUNGER |
5 |
0.0004 |
| 770 |
CELLULITIS |
18 |
0.0004 |
| 771 |
PLATELET COUNT DECREASED |
38 |
0.0004 |
| 772 |
PRESCRIBED UNDERDOSE |
7 |
0.0004 |
| 773 |
INFLAMMATION |
18 |
0.0003 |
| 774 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 775 |
DEVICE DEFECTIVE |
6 |
0.0003 |
| 776 |
MENTAL DISORDER |
15 |
0.0003 |
| 777 |
PRODUCT PREPARATION ERROR |
7 |
0.0003 |
| 778 |
THROMBOCYTOPENIA |
38 |
0.0003 |
| 779 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 780 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 781 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
12 |
0.0003 |
| 782 |
BACTERAEMIA |
4 |
0.0003 |
| 783 |
NEUROPATHY PERIPHERAL |
32 |
0.0003 |
| 784 |
DISEASE RECURRENCE |
16 |
0.0003 |
| 785 |
COLON CANCER |
5 |
0.0003 |
| 786 |
DEVICE ISSUE |
30 |
0.0003 |
| 787 |
RASH PRURITIC |
18 |
0.0003 |
| 788 |
PRODUCT STORAGE ERROR |
29 |
0.0003 |
| 789 |
APHASIA |
10 |
0.0003 |
| 790 |
SKIN DISORDER |
11 |
0.0003 |
| 791 |
NEURALGIA |
8 |
0.0003 |
| 792 |
RETCHING |
7 |
0.0003 |
| 793 |
INSURANCE ISSUE |
5 |
0.0003 |
| 794 |
SKIN CANCER |
7 |
0.0003 |
| 795 |
BRONCHITIS |
24 |
0.0003 |
| 796 |
LIMB DISCOMFORT |
10 |
0.0003 |
| 797 |
SINUSITIS |
33 |
0.0003 |
| 798 |
ILEUS |
4 |
0.0003 |
| 799 |
EPISTAXIS |
24 |
0.0003 |
| 800 |
BASAL CELL CARCINOMA |
5 |
0.0003 |
| 801 |
MENINGIOMA |
5 |
0.0003 |
| 802 |
INJECTION SITE REACTION |
22 |
0.0003 |
| 803 |
MUSCULOSKELETAL STIFFNESS |
28 |
0.0003 |
| 804 |
PAIN IN JAW |
9 |
0.0003 |
| 805 |
FEELING JITTERY |
6 |
0.0003 |
| 806 |
GLOSSODYNIA |
7 |
0.0003 |
| 807 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
4 |
0.0003 |
| 808 |
SKIN ULCER |
8 |
0.0003 |
| 809 |
HIATUS HERNIA |
4 |
0.0003 |
| 810 |
HAEMATOMA |
8 |
0.0003 |
| 811 |
DEAFNESS |
8 |
0.0003 |
| 812 |
DYSPHAGIA |
29 |
0.0003 |
| 813 |
IMPAIRED HEALING |
10 |
0.0003 |
| 814 |
SINUS DISORDER |
6 |
0.0003 |
| 815 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 816 |
RESPIRATORY DISORDER |
9 |
0.0003 |
| 817 |
ILL-DEFINED DISORDER |
18 |
0.0003 |
| 818 |
OCULAR HYPERAEMIA |
14 |
0.0003 |
| 819 |
INJECTION SITE RASH |
9 |
0.0003 |
| 820 |
DRUG ADMINISTRATION ERROR |
9 |
0.0003 |
| 821 |
TREATMENT NONCOMPLIANCE |
16 |
0.0003 |
| 822 |
ERYTHEMA |
60 |
0.0003 |
| 823 |
LOCALISED INFECTION |
7 |
0.0003 |
| 824 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 825 |
BURNING SENSATION |
20 |
0.0003 |
| 826 |
SKIN REACTION |
4 |
0.0003 |
| 827 |
DRUG ERUPTION |
5 |
0.0003 |
| 828 |
INTERNATIONAL NORMALISED RATIO INCREASED |
8 |
0.0003 |
| 829 |
THERAPY INTERRUPTED |
20 |
0.0003 |
| 830 |
HYPOACUSIS |
12 |
0.0003 |
| 831 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 832 |
ALTERED STATE OF CONSCIOUSNESS |
6 |
0.0003 |
| 833 |
ANOSMIA |
4 |
0.0003 |
| 834 |
INJECTION SITE HAEMATOMA |
4 |
0.0003 |
| 835 |
EXPIRED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 836 |
ARTHROPATHY |
15 |
0.0003 |
| 837 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
14 |
0.0003 |
| 838 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 839 |
INJECTION SITE ERYTHEMA |
33 |
0.0003 |
| 840 |
PRURITUS |
102 |
0.0003 |
| 841 |
OSTEOPENIA |
4 |
0.0003 |
| 842 |
HAEMATURIA |
9 |
0.0003 |
| 843 |
GASTRIC DISORDER |
9 |
0.0003 |
| 844 |
SWELLING FACE |
17 |
0.0003 |
| 845 |
WHITE BLOOD CELL COUNT INCREASED |
10 |
0.0003 |
| 846 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 847 |
GLAUCOMA |
5 |
0.0003 |
| 848 |
PNEUMONIA |
84 |
0.0003 |
| 849 |
HAEMORRHAGE |
27 |
0.0003 |
| 850 |
RASH MACULAR |
9 |
0.0003 |
| 851 |
ATRIAL FIBRILLATION |
25 |
0.0003 |
| 852 |
DRUG INEFFECTIVE |
337 |
0.0003 |
| 853 |
PARAESTHESIA |
40 |
0.0003 |
| 854 |
SEPTIC SHOCK |
11 |
0.0003 |
| 855 |
ULCER |
4 |
0.0003 |
| 856 |
CEREBRAL HAEMORRHAGE |
9 |
0.0003 |
| 857 |
GASTROINTESTINAL HAEMORRHAGE |
21 |
0.0003 |
| 858 |
HYPONATRAEMIA |
14 |
0.0002 |
| 859 |
FULL BLOOD COUNT DECREASED |
5 |
0.0002 |
| 860 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 861 |
RESTLESSNESS |
9 |
0.0002 |
| 862 |
PULMONARY OEDEMA |
11 |
0.0002 |
| 863 |
INTENTIONAL DOSE OMISSION |
7 |
0.0002 |
| 864 |
BLINDNESS |
10 |
0.0002 |
| 865 |
HERPES ZOSTER |
14 |
0.0002 |
| 866 |
LUNG NEOPLASM MALIGNANT |
10 |
0.0002 |
| 867 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 868 |
PULMONARY HYPERTENSION |
5 |
0.0002 |
| 869 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0002 |
| 870 |
KNEE ARTHROPLASTY |
5 |
0.0002 |
| 871 |
CHRONIC KIDNEY DISEASE |
18 |
0.0002 |
| 872 |
CARDIOVASCULAR DISORDER |
6 |
0.0002 |
| 873 |
HEMIPARESIS |
4 |
0.0002 |
| 874 |
HEPATITIS |
6 |
0.0002 |
| 875 |
BLISTER |
13 |
0.0002 |
| 876 |
VAGINAL HAEMORRHAGE |
10 |
0.0002 |
| 877 |
DRUG DOSE OMISSION |
38 |
0.0002 |
| 878 |
DISORIENTATION |
9 |
0.0002 |
| 879 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 880 |
ACNE |
17 |
0.0002 |
| 881 |
FEAR |
6 |
0.0002 |
| 882 |
THROAT IRRITATION |
10 |
0.0002 |
| 883 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 884 |
METABOLIC ACIDOSIS |
7 |
0.0002 |
| 885 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0002 |
| 886 |
UPPER RESPIRATORY TRACT INFECTION |
10 |
0.0002 |
| 887 |
COGNITIVE DISORDER |
10 |
0.0002 |
| 888 |
PRODUCT QUALITY ISSUE |
29 |
0.0002 |
| 889 |
EYE PAIN |
12 |
0.0002 |
| 890 |
PHOTOPHOBIA |
4 |
0.0002 |
| 891 |
STAPHYLOCOCCAL INFECTION |
7 |
0.0002 |
| 892 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 893 |
COLITIS |
8 |
0.0002 |
| 894 |
PROTEINURIA |
4 |
0.0002 |
| 895 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 896 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 897 |
ASPARTATE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 898 |
DRUG INTOLERANCE |
20 |
0.0002 |
| 899 |
CARDIAC ARREST |
17 |
0.0002 |
| 900 |
ENCEPHALOPATHY |
5 |
0.0002 |
| 901 |
ACUTE MYOCARDIAL INFARCTION |
6 |
0.0002 |
| 902 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
8 |
0.0002 |
| 903 |
OSTEONECROSIS OF JAW |
5 |
0.0002 |
| 904 |
DELIRIUM |
7 |
0.0002 |
| 905 |
PULMONARY EMBOLISM |
19 |
0.0002 |
| 906 |
SEIZURE |
23 |
0.0002 |
| 907 |
GASTRIC CANCER |
5 |
0.0002 |
| 908 |
PANCYTOPENIA |
11 |
0.0002 |
| 909 |
SKIN IRRITATION |
9 |
0.0002 |
| 910 |
ACUTE KIDNEY INJURY |
30 |
0.0002 |
| 911 |
RENAL FAILURE |
26 |
0.0002 |
| 912 |
THERAPY CESSATION |
10 |
0.0002 |
| 913 |
ELECTROCARDIOGRAM QT PROLONGED |
7 |
0.0002 |
| 914 |
UNDERDOSE |
14 |
0.0002 |
| 915 |
ROAD TRAFFIC ACCIDENT |
8 |
0.0002 |
| 916 |
DYSGEUSIA |
14 |
0.0002 |
| 917 |
SUICIDAL IDEATION |
17 |
0.0002 |
| 918 |
DEVICE MALFUNCTION |
13 |
0.0002 |
| 919 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 920 |
MYOCARDIAL INFARCTION |
32 |
0.0002 |
| 921 |
SKIN LESION |
5 |
0.0002 |
| 922 |
LIP SWELLING |
6 |
0.0002 |
| 923 |
FUNGAL INFECTION |
6 |
0.0002 |
| 924 |
HEPATOTOXICITY |
4 |
0.0002 |
| 925 |
ALANINE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 926 |
THERAPEUTIC RESPONSE UNEXPECTED |
8 |
0.0002 |
| 927 |
CHROMATURIA |
4 |
0.0002 |
| 928 |
RASH |
77 |
0.0002 |
| 929 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
5 |
0.0002 |
| 930 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 931 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
8 |
0.0002 |
| 932 |
INCORRECT DOSE ADMINISTERED |
39 |
0.0002 |
| 933 |
DEEP VEIN THROMBOSIS |
11 |
0.0002 |
| 934 |
ASTHMA |
19 |
0.0002 |
| 935 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 936 |
INTERSTITIAL LUNG DISEASE |
8 |
0.0002 |
| 937 |
EMOTIONAL DISTRESS |
20 |
0.0002 |
| 938 |
MENTAL IMPAIRMENT |
4 |
0.0002 |
| 939 |
TOXICITY TO VARIOUS AGENTS |
27 |
0.0002 |
| 940 |
PRODUCT USE ISSUE |
30 |
0.0002 |
| 941 |
DYSARTHRIA |
6 |
0.0002 |
| 942 |
CEREBROVASCULAR ACCIDENT |
27 |
0.0002 |
| 943 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 944 |
URTICARIA |
26 |
0.0002 |
| 945 |
RESPIRATORY TRACT INFECTION |
4 |
0.0002 |
| 946 |
EYE DISORDER |
5 |
0.0002 |
| 947 |
THERAPEUTIC RESPONSE DECREASED |
9 |
0.0001 |
| 948 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 949 |
RENAL CANCER |
7 |
0.0001 |
| 950 |
HYPERSENSITIVITY |
27 |
0.0001 |
| 951 |
ABNORMAL DREAMS |
4 |
0.0001 |
| 952 |
ANAPHYLACTIC REACTION |
8 |
0.0001 |
| 953 |
LEUKOPENIA |
7 |
0.0001 |
| 954 |
NEUTROPENIA |
19 |
0.0001 |
| 955 |
EYE IRRITATION |
8 |
0.0001 |
| 956 |
PRODUCT SUBSTITUTION ISSUE |
8 |
0.0001 |
| 957 |
DEVICE LEAKAGE |
6 |
0.0001 |
| 958 |
PANIC ATTACK |
5 |
0.0001 |
| 959 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 960 |
HEPATIC FUNCTION ABNORMAL |
5 |
0.0001 |
| 961 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
6 |
0.0001 |
| 962 |
ECZEMA |
7 |
0.0001 |
| 963 |
THERAPY NON-RESPONDER |
6 |
0.0001 |
| 964 |
EPILEPSY |
4 |
0.0001 |
| 965 |
SKIN EXFOLIATION |
11 |
0.0001 |
| 966 |
FEMUR FRACTURE |
4 |
0.0001 |
| 967 |
COMA |
6 |
0.0001 |
| 968 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 969 |
MOVEMENT DISORDER |
4 |
0.0001 |
| 970 |
CARDIAC FAILURE CONGESTIVE |
10 |
0.0001 |
| 971 |
PROSTATE CANCER |
10 |
0.0001 |
| 972 |
WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 973 |
BREAST CANCER |
11 |
0.0001 |
| 974 |
SPEECH DISORDER |
6 |
0.0001 |
| 975 |
RHEUMATOID ARTHRITIS |
13 |
0.0001 |
| 976 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 977 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
| 978 |
HALLUCINATION |
8 |
0.0001 |
| 979 |
DRY EYE |
5 |
0.0001 |
| 980 |
ABORTION SPONTANEOUS |
4 |
0.0001 |
| 981 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 982 |
AGITATION |
7 |
0.0001 |
| 983 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 984 |
LUNG DISORDER |
4 |
0.0001 |
| 985 |
PRODUCT USE IN UNAPPROVED INDICATION |
19 |
0.0001 |
| 986 |
DRUG INTERACTION |
12 |
0.0001 |
| 987 |
CONVULSION |
4 |
0.0001 |
| 988 |
INTENTIONAL PRODUCT USE ISSUE |
6 |
0.0001 |
| 989 |
INJURY |
4 |
0.0001 |
| 990 |
SKIN BURNING SENSATION |
4 |
0.0001 |
| 991 |
DRUG DEPENDENCE |
6 |
0.0000 |
| 992 |
OVERDOSE |
7 |
0.0000 |